Variant report
Variant | esv10824 |
---|---|
Chromosome Location | chr3:22279439-22286398 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181786385 | chr3:22279488-22279489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143850935 | chr3:22279490-22279491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78884155 | chr3:22279537-22279538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141185190 | chr3:22279548-22279549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532684584 | chr3:22279562-22279563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566748071 | chr3:22279564-22279565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552628042 | chr3:22279567-22279568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557736183 | chr3:22279568-22279569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573128052 | chr3:22279573-22279574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558100567 | chr3:22279575-22279576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201978694 | chr3:22279595-22279596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534677856 | chr3:22279622-22279623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552998464 | chr3:22279636-22279637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146223828 | chr3:22279660-22279661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9877955 | chr3:22279685-22279686 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs2728999 | chr3:22279687-22279688 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs575715009 | chr3:22279700-22279701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79549191 | chr3:22279705-22279706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2729000 | chr3:22279788-22279789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs201155968 | chr3:22279789-22279790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528826276 | chr3:22279794-22279795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546607559 | chr3:22279803-22279804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs117812240 | chr3:22279854-22279855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528895918 | chr3:22279858-22279859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187399900 | chr3:22279894-22279895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190435456 | chr3:22279897-22279898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551582757 | chr3:22279938-22279939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566653339 | chr3:22279946-22279947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139281293 | chr3:22279947-22279948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs180885215 | chr3:22279953-22279954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555786934 | chr3:22279994-22279995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575611085 | chr3:22280020-22280021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185944588 | chr3:22280027-22280028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557159528 | chr3:22280051-22280052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575719837 | chr3:22280121-22280122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546076963 | chr3:22280127-22280128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144120756 | chr3:22280139-22280140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368475590 | chr3:22280191-22280192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540879760 | chr3:22280204-22280205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564983799 | chr3:22280217-22280218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562387466 | chr3:22280284-22280285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370768632 | chr3:22280302-22280303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs5847168 | chr3:22280315-22280316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538388472 | chr3:22280365-22280366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550633918 | chr3:22280371-22280372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146513913 | chr3:22280435-22280436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558586721 | chr3:22280444-22280445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190332130 | chr3:22280445-22280446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182773929 | chr3:22280470-22280471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566622066 | chr3:22280508-22280509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22278800-22280400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr3:22279200-22280400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr3:22280400-22280800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr3:22280600-22280800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr3:22284600-22286200 | Weak transcription | NHDF-Ad | bronchial |
6 | chr3:22285600-22287400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr3:22286000-22287600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr3:22286200-22286800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr3:22286200-22287600 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr3:22286200-22287600 | Enhancers | Fetal Stomach | stomach |
11 | chr3:22286200-22287600 | Enhancers | HMEC | breast |
12 | chr3:22286200-22287600 | Enhancers | NHDF-Ad | bronchial |
13 | chr3:22286200-22287600 | Enhancers | NHLF | lung |
14 | chr3:22286200-22288000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr3:22286200-22288000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |